文献速递外周动脉疾病

低高密度脂蛋白胆固醇是有症状外周动脉疾病独立预后标志物

Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease.
PubMed 文献 · J Vasc Surg · 2017-06-27

该研究纳入254例有症状外周动脉疾病患者,平均随访2.7年,评估低HDL-C对缺血事件或死亡的预测价值。多因素分析显示,正常HDL-C组临界肢体缺血风险显著降低(OR 0.09,95%CI 0.03-0.24),死亡风险(HR 0.46,95%CI 0.21-0.99)和主要不良心血管事件风险(HR 0.38,95%CI 0.16-0.86)亦降低。结论认为低HDL-C与心血管并发症及死亡风险升高独立相关。

要点

  • 低HDL-C是有症状PAD患者心血管事件和死亡的独立预后标志物。
  • 正常HDL-C组临界肢体缺血风险显著低于低HDL-C组(OR 0.09)。

核心结论

  • 低HDL-C水平与有症状PAD患者心血管并发症及死亡风险升高显著相关。
  • HDL-C检测有助于早期识别PAD高危患者。

研究设计与样本

  • 研究纳入254例有症状外周动脉疾病患者,记录临床和人口学参数。
  • 平均随访2.7年,记录截肢、缺血性冠心病、脑血管疾病和全因死亡。

主要发现

  • 正常HDL-C组临界肢体缺血风险显著低于低HDL-C组(多因素分析OR 0.09,95%CI 0.03-0.24)。
  • 正常HDL-C组死亡风险降低(HR 0.46,95%CI 0.21-0.99)。
  • 正常HDL-C组主要不良心血管事件风险降低(HR 0.38,95%CI 0.16-0.86)。
  • 上述结果在Cox比例风险模型和Kaplan-Meier估计中经混杂因素校正后一致。

临床怎么用

  • HDL-C可作为简便检测用于PAD患者心血管风险分层。
  • 对低HDL-C的PAD患者应加强心血管事件监测和危险因素管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The prognosis of patients with peripheral arterial disease (PAD) is characterized by an exceptionally high risk for myocardial infarction, ischemic stroke, and death; however, studies in search of new prognostic biomarkers in PAD are scarce. Even though low levels of high-density lipoprotein cholesterol (HDL-C) have been associated with higher risk of cardiovascular (CV) complications and death in different atherosclerotic diseases, recent epidemiologic studies have challenged its prognostic utility. The aim of this study was to test the predictive value of HDL-C as a risk factor for ischemic events or death in symptomatic PAD patients. METHODS: Clinical and demographic parameters of 254 symptomatic PAD patients were recorded. Amputation, ischemic coronary disease, cerebrovascular disease, and all-cause mortality were recorded during a mean follow-up of 2.7 years. RESULTS: Multivariate analyses showed that disease severity (critical limb ischemia) was significantly reduced in patients with normal HDL-C levels compared with the group with low HDL-C levels (multivariate analysis odds ratio, 0.09; 95% confidence interval [CI], 0.03-0.24). A decreased risk for mortality (hazard ratio, 0.46; 95% CI, 0.21-0.99) and major adverse CV events (hazard ratio, 0.38; 95% CI, 0.16-0.86) was also found in patients with normal vs reduced levels of HDL-C in both Cox proportional hazards models and Kaplan-Meier estimates, after adjustment for confounding factors. CONCLUSIONS: Reduced HDL-C levels were significantly associated with higher risk for development of CV complications as well as with mortality in PAD patients. These findings highlight the usefulness of this simple test for early identification of PAD patients at high risk for development of major CV events.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Martinez-Aguilar E, Orbe J, Fernández-Montero A, et al. Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease. J Vasc Surg. 2017. PMID: 28666822. doi:10.1016/j.jvs.2017.04.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。